Godrej Agrovet Limited reported consolidated revenue of ₹9,383 crore for FY25, a decrease from ₹9,561 crore in FY24. Consolidated EBITDA rose to ₹845 crore, and profit before tax increased by 12% to ₹485 crore. Key segments showed improved margins in Animal Feed and Vegetable Oil due to favorable commodity prices, while the Poultry segment faced challenges with lower volumes. Astec LifeSciences continues to navigate demand-supply issues. The company is committed to sustainability and upholding operational efficiencies across its core segments.